2024-0090 this request is to create a BPA for the project as described below. Mclean hospital has been selected as the vendor. DC/DR has mandated regulatory function to monitor controlled…
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- 15DDHQ24A00000008
- Awardee
-
The Mclean Hospital Corporation UEI MCKWJYCWNVN3
- Awarding agency
-
Drug Enforcement Administration
Department of Justice
- Task orders
- 4 $519,651 obligated
Award facts
- Combined order value
- $534,685 Current and potential, with all options
- Last date to order 50% complete
- IDV ceiling 49% used
- $1,062,961.53
- Maximum order
- $1,062,961.53
- Award type
- Single award
- Who can order
- All agencies
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Drug Enforcement Administration established a Blanket Purchase Agreement with The Mclean Hospital Corporation on May 1, 2024, with a ceiling of $1,062,961.53 through April 30, 2029, for specialized scientific expertise in monitoring and regulating controlled substances, regulated chemicals, and emerging drugs.
This is a single-award, indefinite delivery, indefinite quantity vehicle issued without set-aside designation. Place of performance is Belmont, Massachusetts. The BPA enables the DEA to issue task orders for benzodiazepine testing and related regulatory science services that leverage McLean Hospital's clinical research capabilities and expertise in substance abuse and psychiatric pharmacology.
Three BPA calls have been issued. A $114,422.04 firm fixed-price call was awarded August 16, 2024, for benzodiazepine testing with performance from July 18, 2024, through July 17, 2025, and ultimate completion by August 15, 2025. A $141,455.48 firm fixed-price call was issued July 14, 2025, for benzoziazepine testing with ultimate completion by July 13, 2026. A $134,311.86 firm fixed-price call was issued July 14, 2026, for benzodiazepine testing with ultimate completion by July 13, 2027.
Description
2024-0090 this request is to create a BPA for the project as described below. Mclean hospital has been selected as the vendor. DC/DR has mandated regulatory function to monitor controlled substances, regulated chemicals, emerging drugs
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| DOE, mclean hospital, depressants | Drug Enforcement Administration | $144,496 | |
| DOE, mclean hospital, benzodiazepine testing | Drug Enforcement Administration | $134,312 | |
| DOE, mclean hospital, benzodiazepine testing | Drug Enforcement Administration | $141,455 | |
| Title: DOE, mclean hospital, benzodiazepine testing | Drug Enforcement Administration | $99,388 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 15DDHQ24A00000008?
15DDHQ24A00000008 was awarded to The Mclean Hospital Corporation by Drug Enforcement Administration (Department of Justice) on May 1, 2024.
How much is contract 15DDHQ24A00000008 worth?
Orders under 15DDHQ24A00000008 have obligated $519,651. Their combined current value, with exercised options, is $534,685. 15DDHQ24A00000008's own ceiling is $1,062,962. A single order can be worth up to $1,062,962.
How many orders have been placed under contract 15DDHQ24A00000008?
4 orders have been placed under 15DDHQ24A00000008, the latest on September 1, 2026.
Who can order from contract 15DDHQ24A00000008?
15DDHQ24A00000008 is a single award blanket purchase agreement. All agencies can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV